-
1دورية أكاديمية
المؤلفون: Stephane Champiat, Aurélien Marabelle, Anna Spreafico, Mehmet Altan, Todd M Bauer, Osama Rahma, Karen A Autio, Neeta Somaiah, Meredith McKean, Aaron R Hansen, Jan H M Schellens, Willeke Ros, F Stephen Hodi, Jeffrey S Weber, John V Heymach, Herbert Struemper, Sandrine Aspeslagh, Daniel C Cho, Jennifer K Litton, Axel Hoos, Vincent K Lam, Emmett V Schmidt, Sophie Postel-Vinay, Frans L Opdam, Elaine M Paul, Christoph M Ahlers, Helen Zhou, Shelby A Gorman, Maura Watmuff, Kaitlin M Yablonski, Niranjan Yanamandra, Michael J Chisamore
المصدر: Journal for ImmunoTherapy of Cancer, Vol 11, Iss 3 (2023)
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Pamela Munster, Nicholas Iannotti, Daniel C. Cho, John M. Kirkwood, Liza C. Villaruz, Geoffrey T. Gibney, F. Stephen Hodi, Niharika B. Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven O'Day
مصطلحات موضوعية: Cancer, Tumor Biology, Therapeutic Research and Development, Immuno-oncology, Clinical Research and Trials, Clinical Trial Results, Phase I clinical trials, Small Molecule Agents, Kinase inhibitors, Tumor Microenvironment, Immune cells and the microenvironment, Immunotherapy, Checkpoint blockade, Translational Research
الإتاحة: https://doi.org/10.1158/2767-9764.24866726.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Table_7_from_Combination_of_Itacitinib_or_Parsaclisib_with_Pembrolizumab_in_Patients_with_Advanced_Solid_Tumors_A_Phase_I_Study/24866726Test -
3دورية أكاديمية
المؤلفون: Pamela Munster, Nicholas Iannotti, Daniel C. Cho, John M. Kirkwood, Liza C. Villaruz, Geoffrey T. Gibney, F. Stephen Hodi, Niharika B. Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven O'Day
مصطلحات موضوعية: Cancer, Tumor Biology, Therapeutic Research and Development, Immuno-oncology, Clinical Research and Trials, Clinical Trial Results, Phase I clinical trials, Small Molecule Agents, Kinase inhibitors, Tumor Microenvironment, Immune cells and the microenvironment, Immunotherapy, Checkpoint blockade, Translational Research
الإتاحة: https://doi.org/10.1158/2767-9764.24866729.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Table_6_from_Combination_of_Itacitinib_or_Parsaclisib_with_Pembrolizumab_in_Patients_with_Advanced_Solid_Tumors_A_Phase_I_Study/24866729Test -
4دورية أكاديمية
المؤلفون: Pamela Munster, Nicholas Iannotti, Daniel C. Cho, John M. Kirkwood, Liza C. Villaruz, Geoffrey T. Gibney, F. Stephen Hodi, Niharika B. Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven O'Day
مصطلحات موضوعية: Cancer, Tumor Biology, Therapeutic Research and Development, Immuno-oncology, Clinical Research and Trials, Clinical Trial Results, Phase I clinical trials, Small Molecule Agents, Kinase inhibitors, Tumor Microenvironment, Immune cells and the microenvironment, Immunotherapy, Checkpoint blockade, Translational Research
الإتاحة: https://doi.org/10.1158/2767-9764.24866720.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Table_9_from_Combination_of_Itacitinib_or_Parsaclisib_with_Pembrolizumab_in_Patients_with_Advanced_Solid_Tumors_A_Phase_I_Study/24866720Test -
5دورية أكاديمية
المؤلفون: Pamela Munster, Nicholas Iannotti, Daniel C. Cho, John M. Kirkwood, Liza C. Villaruz, Geoffrey T. Gibney, F. Stephen Hodi, Niharika B. Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven O'Day
مصطلحات موضوعية: Cancer, Tumor Biology, Therapeutic Research and Development, Immuno-oncology, Clinical Research and Trials, Clinical Trial Results, Phase I clinical trials, Small Molecule Agents, Kinase inhibitors, Tumor Microenvironment, Immune cells and the microenvironment, Immunotherapy, Checkpoint blockade, Translational Research
الإتاحة: https://doi.org/10.1158/2767-9764.24866732.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Table_5_from_Combination_of_Itacitinib_or_Parsaclisib_with_Pembrolizumab_in_Patients_with_Advanced_Solid_Tumors_A_Phase_I_Study/24866732Test -
6دورية أكاديمية
المؤلفون: Pamela Munster, Nicholas Iannotti, Daniel C. Cho, John M. Kirkwood, Liza C. Villaruz, Geoffrey T. Gibney, F. Stephen Hodi, Niharika B. Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven O'Day
مصطلحات موضوعية: Cancer, Tumor Biology, Therapeutic Research and Development, Immuno-oncology, Clinical Research and Trials, Clinical Trial Results, Phase I clinical trials, Small Molecule Agents, Kinase inhibitors, Tumor Microenvironment, Immune cells and the microenvironment, Immunotherapy, Checkpoint blockade, Translational Research
الإتاحة: https://doi.org/10.1158/2767-9764.24866741.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Table_2_from_Combination_of_Itacitinib_or_Parsaclisib_with_Pembrolizumab_in_Patients_with_Advanced_Solid_Tumors_A_Phase_I_Study/24866741Test -
7دورية أكاديمية
المؤلفون: Pamela Munster, Nicholas Iannotti, Daniel C. Cho, John M. Kirkwood, Liza C. Villaruz, Geoffrey T. Gibney, F. Stephen Hodi, Niharika B. Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven O'Day
مصطلحات موضوعية: Cancer, Tumor Biology, Therapeutic Research and Development, Immuno-oncology, Clinical Research and Trials, Clinical Trial Results, Phase I clinical trials, Small Molecule Agents, Kinase inhibitors, Tumor Microenvironment, Immune cells and the microenvironment, Immunotherapy, Checkpoint blockade, Translational Research
الإتاحة: https://doi.org/10.1158/2767-9764.24866738.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Table_3_from_Combination_of_Itacitinib_or_Parsaclisib_with_Pembrolizumab_in_Patients_with_Advanced_Solid_Tumors_A_Phase_I_Study/24866738Test -
8دورية أكاديمية
المؤلفون: Pamela Munster, Nicholas Iannotti, Daniel C. Cho, John M. Kirkwood, Liza C. Villaruz, Geoffrey T. Gibney, F. Stephen Hodi, Niharika B. Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven O'Day
مصطلحات موضوعية: Cancer, Tumor Biology, Therapeutic Research and Development, Immuno-oncology, Clinical Research and Trials, Clinical Trial Results, Phase I clinical trials, Small Molecule Agents, Kinase inhibitors, Tumor Microenvironment, Immune cells and the microenvironment, Immunotherapy, Checkpoint blockade, Translational Research
الإتاحة: https://doi.org/10.1158/2767-9764.24866744.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Table_10_from_Combination_of_Itacitinib_or_Parsaclisib_with_Pembrolizumab_in_Patients_with_Advanced_Solid_Tumors_A_Phase_I_Study/24866744Test -
9دورية أكاديمية
المؤلفون: Pamela Munster, Nicholas Iannotti, Daniel C. Cho, John M. Kirkwood, Liza C. Villaruz, Geoffrey T. Gibney, F. Stephen Hodi, Niharika B. Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven O'Day
مصطلحات موضوعية: Cancer, Tumor Biology, Therapeutic Research and Development, Immuno-oncology, Clinical Research and Trials, Clinical Trial Results, Phase I clinical trials, Small Molecule Agents, Kinase inhibitors, Tumor Microenvironment, Immune cells and the microenvironment, Immunotherapy, Checkpoint blockade, Translational Research
الإتاحة: https://doi.org/10.1158/2767-9764.24866723.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Table_8_from_Combination_of_Itacitinib_or_Parsaclisib_with_Pembrolizumab_in_Patients_with_Advanced_Solid_Tumors_A_Phase_I_Study/24866723Test -
10دورية أكاديمية
المؤلفون: Pamela Munster, Nicholas Iannotti, Daniel C. Cho, John M. Kirkwood, Liza C. Villaruz, Geoffrey T. Gibney, F. Stephen Hodi, Niharika B. Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven O'Day
مصطلحات موضوعية: Cancer, Tumor Biology, Therapeutic Research and Development, Immuno-oncology, Clinical Research and Trials, Clinical Trial Results, Phase I clinical trials, Small Molecule Agents, Kinase inhibitors, Tumor Microenvironment, Immune cells and the microenvironment, Immunotherapy, Checkpoint blockade, Translational Research
الإتاحة: https://doi.org/10.1158/2767-9764.24866735.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Table_4_from_Combination_of_Itacitinib_or_Parsaclisib_with_Pembrolizumab_in_Patients_with_Advanced_Solid_Tumors_A_Phase_I_Study/24866735Test